5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.05▼ | 1.05▼ | 1.05▼ | 1.01▼ | 0.92▲ |
MA10 | 1.04▼ | 1.04▼ | 1.03▼ | 0.96▲ | 0.91▲ |
MA20 | 1.01▲ | 1.01▲ | 1.00▲ | 0.93▲ | 0.90▲ |
MA50 | 0.96▲ | 0.97▲ | 0.97▲ | 0.94▲ | 1.06▼ |
MA100 | 0.93▲ | 0.91▲ | 0.92▲ | 0.92▲ | N/A |
MA200 | 0.87▲ | 0.87▲ | 0.90▲ | 1.03▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | 0.002▲ | 0.003▲ | 0.014▲ | 0.030▲ |
RSI | 50.901▲ | 51.624▲ | 52.346▲ | 55.940▲ | 50.948▲ |
STOCH | 81.944▲ | 82.051▲ | 83.727▲ | 60.288 | 58.937 |
WILL %R | -63.966 | -63.966 | -42.076 | -40.000 | -26.531 |
CCI | -28.503 | -43.677 | -14.384 | 84.937 | 101.491▲ |
Monday, July 07, 2025 01:10 PM
OXFORD, United Kingdom, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic ...
|
Thursday, June 12, 2025 04:32 AM
The stock price for Barinthus Biotherapeutics (NASDAQ: BRNS) is $0.9 last updated July 3, 2025 at 9:12 AM EDT. Q Does Barinthus Biotherapeutics (BRNS) pay a dividend?
|
Monday, June 09, 2025 09:33 AM
Barinthus Biotherapeutics (NASDAQ:BRNS) is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic candidates for treating autoimmune and inflammatory diseases ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
11/07/25 | 1.005 | 1.01 | 1.00 | 1.00 | 3,683 |
10/07/25 | 1.06 | 1.0792 | 1.05 | 1.06 | 17,407 |
09/07/25 | 1.0175 | 1.10 | 0.941 | 1.06 | 63,162 |
08/07/25 | 0.92 | 1.05 | 0.92 | 0.985 | 60,819 |
07/07/25 | 0.91 | 1.00 | 0.91 | 0.9274 | 48,229 |
03/07/25 | 0.979 | 1.00 | 0.91 | 0.9211 | 16,172 |
02/07/25 | 0.9499 | 0.9998 | 0.93 | 0.946 | 24,902 |
01/07/25 | 0.91 | 0.935 | 0.90 | 0.90 | 13,154 |
30/06/25 | 0.902 | 0.9331 | 0.902 | 0.9301 | 6,136 |
27/06/25 | 0.902 | 0.94 | 0.902 | 0.916 | 2,016 |
|
|
||||
|
|
||||
|
|